Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	histone H3K9 monomethyltransferase activity	SETDB2 MECOM PRDM16	3.82e-06	8	83	3	GO:0140948
GeneOntologyMolecularFunction	histone H3K9me2 methyltransferase activity	SETDB2 MECOM PRDM16	8.14e-06	10	83	3	GO:0140947
GeneOntologyMolecularFunction	histone H3K9 methyltransferase activity	SETDB2 MECOM PRDM16	1.92e-05	13	83	3	GO:0046974
GeneOntologyMolecularFunction	actin binding	EVL MYO3A SYNPO2 MYO9A PLEKHG3 GAS7 FHOD3 ITPRID2 UTRN	1.66e-04	479	83	9	GO:0003779
GeneOntologyMolecularFunction	transmembrane receptor protein serine/threonine kinase binding	MAGI2 SRC SCUBE3	1.88e-04	27	83	3	GO:0070696
GeneOntologyMolecularFunction	receptor serine/threonine kinase binding	MAGI2 SRC SCUBE3	4.12e-04	35	83	3	GO:0033612
GeneOntologyMolecularFunction	cytoskeletal protein binding	MAGI2 EVL MYO3A SYNPO2 MYO9A PLEKHG3 MAST1 GAS7 CCDC187 FHOD3 RP1 ITPRID2 UTRN	5.77e-04	1099	83	13	GO:0008092
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	SETDB2 MECOM PRDM16	8.11e-04	44	83	3	GO:0140938
GeneOntologyMolecularFunction	BMP receptor binding	SRC SCUBE3	1.29e-03	13	83	2	GO:0070700
GeneOntologyBiologicalProcess	brown fat cell differentiation	CEBPB GATA2 MECOM PRDM16 SH2B2	6.58e-06	67	81	5	GO:0050873
GeneOntologyBiologicalProcess	heterochromatin organization	SETDB2 MECOM PRDM16	1.62e-05	13	81	3	GO:0070828
GeneOntologyCellularComponent	photoreceptor inner segment	MAGI2 MYO3A KIAA0586 RP1	2.64e-04	78	83	4	GO:0001917
GeneOntologyCellularComponent	actin filament	MYO3A MYO9A SRC GAS7 SH2B2	2.91e-04	146	83	5	GO:0005884
GeneOntologyCellularComponent	actin cytoskeleton	EVL DENND2A MYO3A SYNPO2 MYO9A SRC GAS7 FHOD3 SH2B2	4.62e-04	576	83	9	GO:0015629
Domain	Evi1/Prdm16	MECOM PRDM16	1.86e-05	2	81	2	IPR030413
Domain	ARM-like	KPNA4 GPRASP1 FHOD3 BTAF1 ARMCX2 TRRAP MED12 KPNA2	2.22e-05	270	81	8	IPR011989
Domain	-	KPNA4 GPRASP1 BTAF1 ARMCX2 TRRAP MED12 KPNA2	5.03e-05	222	81	7	1.25.10.10
Domain	KRAP_IP3R_bind	ITPRID2 TESPA1	5.56e-05	3	81	2	PF14722
Domain	IP3R-bd	ITPRID2 TESPA1	5.56e-05	3	81	2	IPR029325
Domain	KRAP_IP3R_bind	ITPRID2 TESPA1	5.56e-05	3	81	2	SM01257
Domain	Arm_3	KPNA4 KPNA2	3.85e-04	7	81	2	PF16186
Domain	Importing_su_alpha	KPNA4 KPNA2	3.85e-04	7	81	2	IPR024931
Domain	Arm_3	KPNA4 KPNA2	3.85e-04	7	81	2	IPR032413
Domain	IBB	KPNA4 KPNA2	3.85e-04	7	81	2	PF01749
Domain	IBB	KPNA4 KPNA2	5.11e-04	8	81	2	PS51214
Domain	Importin-a_IBB	KPNA4 KPNA2	6.56e-04	9	81	2	IPR002652
Domain	ARM-type_fold	KPNA4 GPRASP1 FHOD3 BTAF1 ARMCX2 TRRAP KPNA2	6.71e-04	339	81	7	IPR016024
Domain	ARM_REPEAT	KPNA4 ARMCX2 KPNA2	6.92e-04	40	81	3	PS50176
Domain	ARM	KPNA4 ARMCX2 KPNA2	6.92e-04	40	81	3	SM00185
Domain	ARM-rpt_dom	GPRASP1 ARMCX2	9.96e-04	11	81	2	IPR006911
Domain	Arm_2	GPRASP1 ARMCX2	9.96e-04	11	81	2	PF04826
Domain	Armadillo	KPNA4 ARMCX2 KPNA2	1.11e-03	47	81	3	IPR000225
Domain	WW	MAGI2 GAS7 UTRN	1.11e-03	47	81	3	PF00397
Domain	WW	MAGI2 GAS7 UTRN	1.18e-03	48	81	3	SM00456
Domain	WW_DOMAIN_2	MAGI2 GAS7 UTRN	1.41e-03	51	81	3	PS50020
Domain	WW_DOMAIN_1	MAGI2 GAS7 UTRN	1.41e-03	51	81	3	PS01159
Domain	WW_dom	MAGI2 GAS7 UTRN	1.49e-03	52	81	3	IPR001202
Domain	PH	PLEKHG3 CYTH3 PLCH2 ASAP3 SH2B2	3.19e-03	229	81	5	PF00169
Domain	-	EVL PLEKHG3 CYTH3 PLCH2 ASAP3 SH2B2	7.03e-03	391	81	6	2.30.29.30
Domain	PH	PLEKHG3 CYTH3 PLCH2 ASAP3 SH2B2	7.20e-03	278	81	5	SM00233
Domain	PH_DOMAIN	PLEKHG3 CYTH3 PLCH2 ASAP3 SH2B2	7.31e-03	279	81	5	PS50003
Domain	PH_domain	PLEKHG3 CYTH3 PLCH2 ASAP3 SH2B2	7.41e-03	280	81	5	IPR001849
Domain	Arm	KPNA4 KPNA2	7.96e-03	31	81	2	PF00514
Domain	RA	MYO9A RASSF6	7.96e-03	31	81	2	SM00314
Pubmed	Characterization of nuclear localization signal in the N terminus of CUL4B and its essential role in cyclin E degradation and cell cycle progression.	KPNA4 CCNE1 KPNA2	2.80e-07	6	85	3	19801544
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RFTN1 PLEKHG3 KIAA0586 GAS7 VARS2 ARMCX2 PRDM16 ATP8B2 MED12 KIAA0753	3.62e-07	493	85	10	15368895
Pubmed	HIV-1 p17 and IFN-gamma both induce fructose 1,6-bisphosphatase.	KPNA4 IFNG KPNA2	1.67e-06	10	85	3	9282826
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	TICRR PPIG CEBPB POLR1E WDR33 GATA2 MECOM XPC SSR3 TRRAP DEK INO80D HNRNPR KPNA2	2.93e-06	1294	85	14	30804502
Pubmed	A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia.	GATA2 MECOM	5.90e-06	2	85	2	24703711
Pubmed	A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells.	MECOM PRDM16	5.90e-06	2	85	2	11050005
Pubmed	A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expression.	GATA2 MECOM	5.90e-06	2	85	2	24703906
Pubmed	Evi-1 promotes para-aortic splanchnopleural hematopoiesis through up-regulation of GATA-2 and repression of TGF-b signaling.	GATA2 MECOM	5.90e-06	2	85	2	18452556
Pubmed	High expression of EVI1 and MEL1 is a compelling poor prognostic marker of pediatric AML.	MECOM PRDM16	5.90e-06	2	85	2	25567132
Pubmed	EVI1 and GATA2 misexpression induced by inv(3)(q21q26) contribute to megakaryocyte-lineage skewing and leukemogenesis.	GATA2 MECOM	5.90e-06	2	85	2	32330245
Pubmed	Induction by EGF and interferon-gamma of tyrosine phosphorylated DNA binding proteins in mouse liver nuclei.	IFNG EGF	5.90e-06	2	85	2	8378774
Pubmed	GATA2 haploinsufficiency accelerates EVI1-driven leukemogenesis.	GATA2 MECOM	5.90e-06	2	85	2	28630119
Pubmed	Tespa1 protein is phosphorylated in response to store-operated calcium entry.	ITPRID2 TESPA1	5.90e-06	2	85	2	23541577
Pubmed	Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16.	MECOM PRDM16	5.90e-06	2	85	2	18496560
Pubmed	The shortest isoform of C/EBPβ, liver inhibitory protein (LIP), collaborates with Evi1 to induce AML in a mouse BMT model.	CEBPB MECOM	5.90e-06	2	85	2	23547050
Pubmed	The methylation of C/EBP β gene promoter and regulated by GATA-2 protein.	CEBPB GATA2	5.90e-06	2	85	2	23065276
Pubmed	Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells.	MECOM PRDM16	5.90e-06	2	85	2	16109773
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	KPNA4 RFTN1 CEBPB BMP2K POLR1E PLEKHG3 XPC RPS26 ITPRID2 SSR3 TRRAP UTRN INO80D MED12	1.53e-05	1497	85	14	31527615
Pubmed	EGF-induced C/EBPβ participates in EMT by decreasing the expression of miR-203 in esophageal squamous cell carcinoma cells.	CEBPB EGF	1.77e-05	3	85	2	24994936
Pubmed	The conserved and divergent roles of Prdm3 and Prdm16 in zebrafish and mouse craniofacial development.	MECOM PRDM16	1.77e-05	3	85	2	32044379
Pubmed	In vitro phosphorylation of the epidermal growth factor receptor autophosphorylation domain by c-src: identification of phosphorylation sites and c-src SH2 domain binding sites.	EGF SRC	1.77e-05	3	85	2	8845374
Pubmed	Epidermal growth factor down-regulates the expression of human hepatic stimulator substance via CCAAT/enhancer-binding protein β in HepG2 cells.	CEBPB EGF	1.77e-05	3	85	2	20690902
Pubmed	Prdm3 and Prdm16 cooperatively maintain hematopoiesis and clonogenic potential.	MECOM PRDM16	1.77e-05	3	85	2	32437910
Pubmed	Cloning of a cDNA encoding a novel importin-alpha homologue, Qip1: discrimination of Qip1 and Rch1 from hSrp1 by their ability to interact with DNA helicase Q1/RecQL.	KPNA4 KPNA2	1.77e-05	3	85	2	9168958
Pubmed	MEKK1 plays a critical role in activating the transcription factor C/EBP-beta-dependent gene expression in response to IFN-gamma.	IFNG CEBPB	1.77e-05	3	85	2	12048245
Pubmed	C/EBPbeta mediates synergistic upregulation of gene expression by interferon-gamma and tumor necrosis factor-alpha in bone marrow-derived mesenchymal stem cells.	IFNG CEBPB	1.77e-05	3	85	2	19353522
Pubmed	Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.	MECOM PRDM16	1.77e-05	3	85	2	16582916
Pubmed	Zinc transporter ZIP13 suppresses beige adipocyte biogenesis and energy expenditure by regulating C/EBP-β expression.	CEBPB PRDM16	1.77e-05	3	85	2	28854265
Pubmed	The Med1 subunit of transcriptional mediator plays a central role in regulating CCAAT/enhancer-binding protein-beta-driven transcription in response to interferon-gamma.	IFNG CEBPB	1.77e-05	3	85	2	18339625
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	SETDB2 POLR1E BOD1L1 BTAF1 XPC EYA3 TRRAP DEK KPNA2	1.82e-05	608	85	9	36089195
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	KPNA4 POLR1E GATA2 AEBP2 MECOM SPAG7 VARS2 SSR3 TRRAP INO80D MED12 HNRNPR KPNA2	1.97e-05	1327	85	13	32694731
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	KPNA4 AEBP2 BOD1L1 ARMCX2 TRRAP DEK KPNA2 LRRC47	2.00e-05	469	85	8	27634302
Pubmed	A protein interaction landscape of breast cancer.	KPNA4 CCNE1 EVL BMP2K AEBP2 XPC ITPRID2 RRAD HNRNPR	2.52e-05	634	85	9	34591612
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	WDR33 PDAP1 MECOM SPAG7 XPC UTRN MED12 KIAA0753 LRRC47	2.89e-05	645	85	9	25281560
Pubmed	Odorant and vomeronasal receptor genes in two mouse genome assemblies.	OR8D2 OR12D1 OR1A1 OR2W1	3.36e-05	74	85	4	15081110
Pubmed	MERS-CoV 4b protein interferes with the NF-κB-dependent innate immune response during infection.	KPNA4 KPNA2	3.53e-05	4	85	2	29370303
Pubmed	Nuclear import of transcriptional corepressor BCOR occurs through interaction with karyopherin α expressed in human periodontal ligament.	KPNA4 KPNA2	3.53e-05	4	85	2	30396568
Pubmed	Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.	EGF SRC	3.53e-05	4	85	2	16636672
Pubmed	Acetylation of lysine 564 adjacent to the C-terminal binding protein-binding motif in EVI1 is crucial for transcriptional activation of GATA2.	GATA2 MECOM	3.53e-05	4	85	2	20363750
Pubmed	Nuclear exportin receptor CAS regulates the NPI-1-mediated nuclear import of HIV-1 Vpr.	KPNA4 KPNA2	3.53e-05	4	85	2	22110766
Pubmed	Interaction between GATA and the C/EBP family of transcription factors is critical in GATA-mediated suppression of adipocyte differentiation.	CEBPB GATA2	3.53e-05	4	85	2	15632071
Pubmed	Epidermal growth factor receptor translocation to the mitochondria: regulation and effect.	EGF SRC	3.53e-05	4	85	2	19840943
Pubmed	Characterisation of alpha-dystrobrevin in muscle.	SRC UTRN	3.53e-05	4	85	2	9701558
Pubmed	Interferon gamma is recognised by importin alpha/beta: enhanced nuclear localising and transactivation activities of an interferon gamma mimetic.	IFNG KPNA2	3.53e-05	4	85	2	18405666
Pubmed	CD40 and tumour necrosis factor-α co-operate to up-regulate inducuble nitric oxide synthase expression in macrophages.	IFNG CEBPB	3.53e-05	4	85	2	22044243
Pubmed	Promotion of importin alpha-mediated nuclear import by the phosphorylation-dependent binding of cargo protein to 14-3-3.	SYNPO2 KPNA2	3.53e-05	4	85	2	15883195
Pubmed	Retroviral insertions in the CB-1/Fim-3 common site of integration activate expression of the Evi-1 gene.	EGF MECOM	3.53e-05	4	85	2	2542863
Pubmed	Molecular determinants for nuclear import of influenza A PB2 by importin α isoforms 3 and 7.	KPNA4 KPNA2	3.53e-05	4	85	2	25599645
Pubmed	Development of a pipeline for automated, high-throughput analysis of paraspeckle proteins reveals specific roles for importin α proteins.	KPNA4 KPNA2	3.53e-05	4	85	2	28240251
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	PLEKHG3 SRC CLTA BTAF1 RPS26 ITPRID2 TRRAP DEK UTRN HNRNPR KPNA2	3.99e-05	1024	85	11	24711643
Pubmed	A role for mixed lineage kinases in regulating transcription factor CCAAT/enhancer-binding protein-{beta}-dependent gene expression in response to interferon-{gamma}.	IFNG CEBPB	5.87e-05	5	85	2	15878863
Pubmed	The PU.1-Modulated MicroRNA-22 Is a Regulator of Monocyte/Macrophage Differentiation and Acute Myeloid Leukemia.	GATA2 MECOM	5.87e-05	5	85	2	27617961
Pubmed	Inhibition of HIV-1 integrase nuclear import and replication by a peptide bearing integrase putative nuclear localization signal.	KPNA4 KPNA2	5.87e-05	5	85	2	19961612
Pubmed	Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation.	EGF SRC	5.87e-05	5	85	2	9020193
Pubmed	p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2.	CCNE1 SRC	5.87e-05	5	85	2	17254967
Pubmed	Mouse Eya homologues of the Drosophila eyes absent gene require Pax6 for expression in lens and nasal placode.	SRC EYA3	5.87e-05	5	85	2	9006082
Pubmed	IL-6 amplifier, NF-κB-triggered positive feedback for IL-6 signaling, in grafts is involved in allogeneic rejection responses.	IFNG EGF	5.87e-05	5	85	2	22798669
Pubmed	Prdm3 and Prdm16 are H3K9me1 methyltransferases required for mammalian heterochromatin integrity.	MECOM PRDM16	5.87e-05	5	85	2	22939622
Pubmed	Eyes absent: a gene family found in several metazoan phyla.	SRC EYA3	5.87e-05	5	85	2	9195991
Pubmed	PRDM3/16 regulate chromatin accessibility required for NKX2-1 mediated alveolar epithelial differentiation and function.	MECOM PRDM16	5.87e-05	5	85	2	39284798
Pubmed	Identification of novel homologues of mouse importin alpha, the alpha subunit of the nuclear pore-targeting complex, and their tissue-specific expression.	KPNA4 KPNA2	5.87e-05	5	85	2	9369227
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	EVL CEBPB CLTA PDAP1 SPAG7 EYA3 TRRAP DEK INO80D MED12 HNRNPR	7.76e-05	1103	85	11	34189442
Pubmed	HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP.	MYO3A TRRAP UTRN	7.98e-05	34	85	3	25925205
Pubmed	TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.	KPNA4 CCNE1 CEBPB WDR33 GATA2 MECOM RPS26 ITPRID2 HNRNPR KPNA2	8.48e-05	922	85	10	27609421
Pubmed	Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import.	KPNA4 KPNA2	8.80e-05	6	85	2	8551560
Pubmed	Protein tyrosine kinase 6 directly phosphorylates AKT and promotes AKT activation in response to epidermal growth factor.	EGF SRC	8.80e-05	6	85	2	20606012
Pubmed	Distinct effects of importin α2 and α4 on Oct3/4 localization and expression in mouse embryonic stem cells.	KPNA4 KPNA2	8.80e-05	6	85	2	21840941
Pubmed	p17 and p17-containing gag precursors of input human immunodeficiency virus are transported into the nuclei of infected cells.	KPNA4 KPNA2	8.80e-05	6	85	2	2064827
Pubmed	Backbone cyclic peptide, which mimics the nuclear localization signal of human immunodeficiency virus type 1 matrix protein, inhibits nuclear import and virus production in nondividing cells.	KPNA4 KPNA2	8.80e-05	6	85	2	9548947
Pubmed	The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells.	KPNA4 KPNA2	8.80e-05	6	85	2	9557700
Pubmed	A role for human immunodeficiency virus type 1 Vpr during infection of peripheral blood mononuclear cells.	KPNA4 KPNA2	8.80e-05	6	85	2	9603322
Pubmed	CNI-H0294, a nuclear importation inhibitor of the human immunodeficiency virus type 1 genome, abrogates virus replication in infected activated peripheral blood mononuclear cells.	KPNA4 KPNA2	8.80e-05	6	85	2	9593140
Pubmed	HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase.	KPNA4 KPNA2	8.80e-05	6	85	2	7585960
Pubmed	Three distinct classes of the alpha-subunit of the nuclear pore-targeting complex (importin-alpha) are differentially expressed in adult mouse tissues.	KPNA4 KPNA2	8.80e-05	6	85	2	10026238
Pubmed	The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells.	KPNA4 KPNA2	8.80e-05	6	85	2	8041786
Pubmed	The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes.	KPNA4 KPNA2	8.80e-05	6	85	2	8041734
Pubmed	HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import.	KPNA4 KPNA2	8.80e-05	6	85	2	9303297
Pubmed	Inhibition of nuclear import by backbone cyclic peptidomimetics derived from the HIV-1 MA NLS sequence.	KPNA4 KPNA2	8.80e-05	6	85	2	11904219
Pubmed	Phenotype of HIV-1 lacking a functional nuclear localization signal in matrix protein of gag and Vpr is comparable to wild-type HIV-1 in primary macrophages.	KPNA4 KPNA2	8.80e-05	6	85	2	9918876
Pubmed	Identification and characterization of a nuclear localization signal of TRIM28 that overlaps with the HP1 box.	KPNA4 KPNA2	8.80e-05	6	85	2	25960296
Pubmed	HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator.	KPNA4 KPNA2	8.80e-05	6	85	2	7859280
Pubmed	Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.	KPNA4 KPNA2	8.80e-05	6	85	2	8529100
Pubmed	Epidermal growth factor stimulates RSK2 activation through activation of the MEK/ERK pathway and src-dependent tyrosine phosphorylation of RSK2 at Tyr-529.	EGF SRC	8.80e-05	6	85	2	18156174
Pubmed	Karyopherin alpha7 (KPNA7), a divergent member of the importin alpha family of nuclear import receptors.	KPNA4 KPNA2	8.80e-05	6	85	2	20701745
Pubmed	Importin alpha1 (Rch1) mediates nuclear translocation of thioredoxin-binding protein-2/vitamin D(3)-up-regulated protein 1.	DNAJB4 KPNA2	8.80e-05	6	85	2	15234975
Pubmed	Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection.	KPNA4 KPNA2	8.80e-05	6	85	2	9008157
Pubmed	A synthetic peptide bearing the HIV-1 integrase 161-173 amino acid residues mediates active nuclear import and binding to importin alpha: characterization of a functional nuclear localization signal.	KPNA4 KPNA2	8.80e-05	6	85	2	15037073
Pubmed	Critical role of reverse transcriptase in the inhibitory mechanism of CNI-H0294 on HIV-1 nuclear translocation.	KPNA4 KPNA2	8.80e-05	6	85	2	8876228
Pubmed	Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection.	KPNA4 KPNA2	8.80e-05	6	85	2	7745752
Pubmed	Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion.	KPNA4 KPNA2	8.80e-05	6	85	2	8659115
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	KPNA4 SYNPO2 PLCH2 ASAP3 ITPRID2 FOXI1 KPNA2	9.06e-05	430	85	7	35044719
Pubmed	Inhibition of Src family kinases blocks epidermal growth factor (EGF)-induced activation of Akt, phosphorylation of c-Cbl, and ubiquitination of the EGF receptor.	EGF SRC	1.23e-04	7	85	2	11994282
Pubmed	Evidence for distinct substrate specificities of importin alpha family members in nuclear protein import.	KPNA4 KPNA2	1.23e-04	7	85	2	10523667
Pubmed	GIT1 mediates Src-dependent activation of phospholipase Cgamma by angiotensin II and epidermal growth factor.	EGF SRC	1.23e-04	7	85	2	14523024
Pubmed	Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression.	IFNG CEBPB	1.23e-04	7	85	2	10775602
Pubmed	The adapter protein APS associates with the multifunctional docking sites Tyr-568 and Tyr-936 in c-Kit.	SRC SH2B2	1.23e-04	7	85	2	12444928
Pubmed	Maternal epigenetic factors in embryonic and postnatal development.	MECOM PRDM16	1.23e-04	7	85	2	36906847
Pubmed	Active nuclear import and cytoplasmic retention of activation-induced deaminase.	KPNA4 KPNA2	1.23e-04	7	85	2	19412186
Pubmed	SynArfGEF is a guanine nucleotide exchange factor for Arf6 and localizes preferentially at post-synaptic specializations of inhibitory synapses.	MAGI2 UTRN	1.23e-04	7	85	2	21198641
Pubmed	Cloning and characterization of two vertebrate homologs of the Drosophila eyes absent gene.	CEBPB EYA3	1.23e-04	7	85	2	9049631
Interaction	CA3 interactions	SRC MECOM TRRAP	1.01e-05	11	81	3	int:CA3
Interaction	KHDRBS1 interactions	CEBPB SRC MECOM GAS7 ITPRID2 TRRAP PRDM16 MED12 HNRNPR	1.87e-05	373	81	9	int:KHDRBS1
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	KPNA4 GPRASP1 ARMCX2 KPNA2	8.04e-06	43	54	4	409
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	SETDB2 MECOM PRDM16	1.41e-04	34	54	3	487
GeneFamily	Zinc fingers C2H2-type\|PR/SET domain family	MECOM PRDM16	1.16e-03	17	54	2	1197
GeneFamily	Armadillo repeat containing\|Importins	KPNA4 KPNA2	1.30e-03	18	54	2	596
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHG3 CYTH3 ASAP3 SH2B2	3.32e-03	206	54	4	682
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500	TICRR PPIG CHRNA9 PRR36 PLCH2 GATA2 PDAP1 DYNC2I1 MECOM PRDM16	1.40e-05	492	79	10	Facebase_RNAseq_e10.5_Maxillary Arch_500
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A EGF MYO9A MECOM RP1 PRDM16 UTRN	7.73e-08	189	85	7	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	Fibroblast-D_(Pericyte)\|World / shred on cell class and cell subclass (v4)	SYNPO2 PLEKHG3 SCUBE3 DNAJB4 RRAD ARMCX2 TSLP	8.61e-08	192	85	7	8c13c351fcc3d88e8c2ffa017e71ff6272cc6fac
ToppCell	COVID-19-kidney-TAL\|kidney / Disease (COVID-19 only), tissue and cell type	DENND2A EGF MYO9A MECOM RP1 ITPRID2 PRDM16	9.90e-08	196	85	7	04f5eb206ed3016a737609a3ebac0c1fcabb94ef
ToppCell	facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DENND2A SYNPO2 RASSF6 SRC RRAD TSLP	1.19e-06	178	85	6	8bae5db100f4563aa1fc7f881e7f8c59d669e37a
ToppCell	facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DENND2A SYNPO2 RASSF6 SRC RRAD TSLP	1.19e-06	178	85	6	bc0336692b84bd0fa49747ed5a031b8ed8afa0fd
ToppCell	facs-Lung-18m-Mesenchymal-myofibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DENND2A SYNPO2 RASSF6 SRC RRAD TSLP	1.31e-06	181	85	6	dff264815a3569f5666d0bbc3867c0496cd78774
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A EGF MECOM FHOD3 RP1 PRDM16	1.49e-06	185	85	6	03f64a7132b13a01ba47187e0e15c13ac88f7cb2
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A EGF MECOM FHOD3 RP1 PRDM16	1.54e-06	186	85	6	1850583d23903d08226aeb0edb3e07b0994330e4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A EGF MECOM FHOD3 RP1 PRDM16	1.54e-06	186	85	6	4dafc215c42e7949f932a3627359c107943b5d6b
ToppCell	COVID-19-kidney-Mito-rich_Distal\|kidney / Disease (COVID-19 only), tissue and cell type	DENND2A EGF MECOM RP1 PRDM16 INO80D	1.58e-06	187	85	6	2ce8038d9d1302e850c1bb536e755598f77ba4b9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A EGF MECOM RP1 ITPRID2 PRDM16	1.63e-06	188	85	6	2ee64bc73a2251fd9f374be759b442cf4ed0d19e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EGF MYO9A MECOM FHOD3 RP1 PRDM16	2.02e-06	195	85	6	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BMP2K VWA5A GATA2 GAS7 TESPA1	1.05e-05	151	85	5	f5ae450e3daa10540ca8437d05efe2d86ac70960
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Mast_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BMP2K VWA5A GATA2 GAS7 TESPA1	1.19e-05	155	85	5	231fbbbd6e6f9c86be7a15a9ec0804e6b9ab3b5f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BMP2K VWA5A GATA2 GAS7 TESPA1	1.57e-05	164	85	5	2c48c6e4eeee845f0563982d0bfa2a176ca5ef61
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BMP2K VWA5A GATA2 GAS7 TESPA1	1.71e-05	167	85	5	a813b95c2fafb638b249bc4fa4f708c6f39ad444
ToppCell	Control-Mast_cells\|Control / group, cell type (main and fine annotations)	BMP2K VWA5A GATA2 GAS7 TESPA1	1.81e-05	169	85	5	fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb
ToppCell	Control-Mast_cells-Mast_cells\|Control / group, cell type (main and fine annotations)	BMP2K VWA5A GATA2 GAS7 TESPA1	1.87e-05	170	85	5	c80f6d29096c372da95a8407f402349ff1bb7018
ToppCell	10x5'-Lung-Lymphocytic_T_CD8-Trm_gut_CD8\|Lung / Manually curated celltypes from each tissue	IFNG GPRASP1 EVL TICRR DNAJB4	1.92e-05	171	85	5	c8ccb7795ce8321739e3bc07db2ffc183d04e660
ToppCell	3'_v3-GI_small-bowel-Mast-Mast_cell_granulo-myelo\|GI_small-bowel / Manually curated celltypes from each tissue	TICRR BMP2K VWA5A GATA2 MAST1	1.97e-05	172	85	5	3df11aefc09762fd1f94441324551178e030b249
ToppCell	10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	VWA5A GATA2 MECOM TSLP TESPA1	2.03e-05	173	85	5	1e4afa020fae682521335b440ccd33c16f37156f
ToppCell	facs-Lung-Endomucin-24m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNPO2 SRC ASAP3 SCUBE3 RRAD	2.03e-05	173	85	5	a37f38478473290fe35aea8684befc3bf95b161f
ToppCell	368C-Myeloid-Mast_cell\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	BMP2K VWA5A GATA2 DNAJB4 TESPA1	2.03e-05	173	85	5	8cffb4a37d30b6626188309b868ac4a62e91262f
ToppCell	368C-Myeloid-Mast_cell-\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	BMP2K VWA5A GATA2 DNAJB4 TESPA1	2.03e-05	173	85	5	fb87ea74bf70aa83b458edf728c81857c8b8eb96
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A EGF MECOM RP1 PRDM16	2.14e-05	175	85	5	e5467dacf81f1f913b1719931cf1a7331434a7e7
ToppCell	facs-Lung-EPCAM-18m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND2A SYNPO2 RASSF6 SRC TSLP	2.14e-05	175	85	5	d2ff8fedca9039cbd45cfd9dec88f4edbe7fe4fc
ToppCell	facs-Lung-EPCAM-18m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND2A SYNPO2 RASSF6 SRC TSLP	2.14e-05	175	85	5	a7310950e8d51b3004ea3aee8ce9948fe8655112
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A EGF MECOM RP1 PRDM16	2.33e-05	178	85	5	4df6218b20c2f076c22346d23260964cc0d73e65
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BMP2K VWA5A GATA2 GAS7 TESPA1	2.33e-05	178	85	5	af9bcee71fb44a6342d4b92bba5b8ddfeeaa24b2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EGF SCUBE3 MECOM FHOD3 PRDM16	2.39e-05	179	85	5	666072c0e8448dbaec1683d18368ec2502453f90
ToppCell	COVID-19-Heart-EC_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RFTN1 GATA2 MECOM PRDM16 UTRN	2.39e-05	179	85	5	2a53d94f6c30bf887dfe88f1693ea057218c852d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A EGF MECOM RP1 PRDM16	2.45e-05	180	85	5	eee71184ebed2694d3e60f579a44b3cf7dd2cd35
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FHAD1 DYNC2I1 CC2D2A RP1 RRAD	2.45e-05	180	85	5	1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A EGF MECOM RP1 PRDM16	2.45e-05	180	85	5	a17dbe03597b81e7a1fe2bf2d23e59e55c615a2a
ToppCell	COVID-19-Heart-EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DENND2A RFTN1 SYNPO2 CYTH3 MECOM	2.59e-05	182	85	5	e67f3234165199085c793915ebb1f9bbd845e933
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DENND2A SYNPO2 CYTH3 MECOM GAS7	2.59e-05	182	85	5	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	COVID-19-Heart-CM_4\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SYNPO2 EGF FHOD3 RRAD PRDM16	2.66e-05	183	85	5	2902b6e8aa9a6f62bc1a792c971ab7f651a8e676
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EGF SCUBE3 MECOM FHOD3 PRDM16	2.66e-05	183	85	5	2e831a4d99c6f983793df71c0994124c943c6da9
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A EGF MECOM RP1 PRDM16	2.73e-05	184	85	5	e8238fe58f94b4f5700ab7f343fb06ea61e899a9
ToppCell	IPF-Myeloid-Mast\|IPF / Disease state, Lineage and Cell class	BMP2K VWA5A CYTH3 GATA2 TESPA1	2.73e-05	184	85	5	c3baf21f10b45cf91ac99997a59f353bcf3de8b7
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GATA2 MECOM EYA3 PRDM16 FOXI1	2.80e-05	185	85	5	3d73b3e0bceb192257e5cfbe64b7ccb379b6e22d
ToppCell	COPD-Myeloid-Mast\|COPD / Disease state, Lineage and Cell class	BMP2K VWA5A CYTH3 GATA2 TESPA1	2.87e-05	186	85	5	def6f0f284acc2154738574c8c5d3d2a5ef1f208
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GATA2 MECOM FHOD3 EYA3 PRDM16	2.87e-05	186	85	5	08632045d499e61dd96ff29a5a9a208afe58dc58
ToppCell	COVID-19-Heart-EC_2\|Heart / Disease (COVID-19 only), tissue and cell type	RFTN1 GATA2 MECOM PRDM16 UTRN	2.95e-05	187	85	5	40ffc06a3e3251d9b12da390210d3e045af7537a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A EGF MECOM RP1 PRDM16	2.95e-05	187	85	5	7ea8731288e2a99f45e3958590ee1d76f49ae888
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GATA2 MECOM FHOD3 EYA3 PRDM16	2.95e-05	187	85	5	f6217d0dd425eac76900b44a4e48f45475f3ac36
ToppCell	P07-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PLEKHG3 SCUBE3 DNAJB4 RRAD TSLP	3.02e-05	188	85	5	6ec22b79b19d57ea187f312907819dc2d01f3efe
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A EGF MECOM RP1 PRDM16	3.02e-05	188	85	5	3cee9916399e2e7580cecbcbb27424a71e7e7ac0
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GATA2 MECOM FHOD3 EYA3 PRDM16	3.10e-05	189	85	5	3a295c215b5c18e7c673f92b7af5be523421682c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A EGF MECOM RP1 PRDM16	3.10e-05	189	85	5	f51cdc9a47371cab8ed9ae63a6f14da07ede446c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A EGF MECOM FHOD3 PRDM16	3.10e-05	189	85	5	977a813e5d7a5a561c1fced2bbf21c20056b88d8
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GATA2 MECOM EYA3 PRDM16 FOXI1	3.10e-05	189	85	5	a9864873b19ab3e60acf11f288fa7275badc2e42
ToppCell	3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IFNG BMP2K VWA5A GATA2 TESPA1	3.10e-05	189	85	5	d26af19fd7e0c7eb78a5a3a245ca5229c4e9e847
ToppCell	5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BMP2K VWA5A GATA2 DNAJB4 TESPA1	3.10e-05	189	85	5	f01158bb15df3117fae1271bf8cf8c2501422671
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A EGF MECOM RP1 PRDM16	3.18e-05	190	85	5	b94df372bc08de11585b2467dba8c8fffff5cd92
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A EGF MECOM RP1 PRDM16	3.18e-05	190	85	5	3dcadabbefe0128a5f30ab51234f049ab4d870c6
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A EGF MECOM RP1 PRDM16	3.18e-05	190	85	5	cc17ab84a9328124f146951c06be3eff9650d9fd
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A EGF MECOM FHOD3 PRDM16	3.18e-05	190	85	5	e252e925600e6457fa6e362a55217f4cffa75cdb
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A EGF MECOM RP1 PRDM16	3.26e-05	191	85	5	963f4f2e852bbb4faf070aafb0d368297abacd3b
ToppCell	10x5'v1-week_14-16-Hematopoietic-MK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	EGF SRC GATA2 MECOM TESPA1	3.26e-05	191	85	5	7edc22e7e70697fb22690699efb352577162709b
ToppCell	390C-Myeloid-Mast_cell\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	BMP2K VWA5A GATA2 DNAJB4 TESPA1	3.34e-05	192	85	5	201d430af1e4fee7bc03baf0aca17db26f6f439a
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GATA2 MECOM EYA3 PRDM16 FOXI1	3.34e-05	192	85	5	40f44ac4ab673ee6156abdd2074a60b9de3281ad
ToppCell	ASK454-Immune-Mast_cell\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	NACA2 BMP2K VWA5A GATA2 TESPA1	3.34e-05	192	85	5	4ab2524cce70b6a3a3dd31085b421565a7406c56
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A EGF MECOM RP1 PRDM16	3.34e-05	192	85	5	562df5e87038c500dd3a003fe5374cb31946b145
ToppCell	ASK454-Immune-Mast_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	NACA2 BMP2K VWA5A GATA2 TESPA1	3.34e-05	192	85	5	01e6324146ea34785b770231b40f7a18f128f526
ToppCell	PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DENND2A SRC RRAD ARMCX2 TSLP	3.34e-05	192	85	5	158cc5736f154da1cb3186ffbf186eae10483e48
ToppCell	390C-Myeloid-Mast_cell-\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	BMP2K VWA5A GATA2 DNAJB4 TESPA1	3.34e-05	192	85	5	15c1a0a0d07106118427135f166a1da710bf621a
ToppCell	P15-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SYNPO2 PLEKHG3 SCUBE3 DNAJB4 RRAD	3.34e-05	192	85	5	a476895b7b252c388d6346eacbc72f0115b1443e
ToppCell	PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DENND2A SRC RRAD ARMCX2 TSLP	3.34e-05	192	85	5	f4ff62ac9c53eafbe917706de9af8b2d4bded4d4
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SYNPO2 PLEKHG3 SCUBE3 DNAJB4 RRAD	3.42e-05	193	85	5	88916d9a7d831eb52848599917c04238f8f9812b
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SYNPO2 PLEKHG3 SCUBE3 DNAJB4 RRAD	3.42e-05	193	85	5	7fc3ab7261c88c1df71744bf5b17e8e46c4300e0
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EGF MYO9A MECOM FHOD3 PRDM16	3.51e-05	194	85	5	93c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCell	Bronchial_Brush-Epithelial-Ciliated_1\|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	FHAD1 DYNC2I1 CC2D2A RP1 RRAD	3.51e-05	194	85	5	b4ce60c06568123008b1081d644733cb91c28f51
ToppCell	Bronchial_Brush-Epithelial-Ciliated_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	FHAD1 DYNC2I1 CC2D2A RP1 RRAD	3.51e-05	194	85	5	7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FHAD1 DYNC2I1 CCDC187 RP1 RRAD	3.51e-05	194	85	5	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	distal-Epithelial-Differentiating_Basal-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PRR36 RASSF6 PLCH2 SCUBE3 PRDM16	3.60e-05	195	85	5	3fe6e49a9161fc9e5160251e6932cb5378175a54
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SYNPO2 PLEKHG3 SCUBE3 DNAJB4 RRAD	3.60e-05	195	85	5	c51b1bee79e77aa2ac444a4883ef533c0095eaad
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SYNPO2 PLEKHG3 SCUBE3 DNAJB4 RRAD	3.60e-05	195	85	5	43d372373367b71243c6ea958aedccde4478618f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EGF MYO9A MECOM FHOD3 PRDM16	3.69e-05	196	85	5	eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FHAD1 DYNC2I1 CC2D2A RP1 RRAD	3.78e-05	197	85	5	91637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell	NS-moderate-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FHAD1 DYNC2I1 CC2D2A RP1 RRAD	3.78e-05	197	85	5	71fea4aa6ce96c7693fa94792d08770622873850
ToppCell	Transverse-(5)_Dendritic_cell-(53)_Lymphoid_DC\|Transverse / shred on region, Cell_type, and subtype	DNHD1 SYNPO2 BMP2K PLEKHG3 RRAD	3.78e-05	197	85	5	15b87fd3906d7388c271d30d0c64b1bcc490801c
ToppCell	Transverse-Dendritic_cell-Lymphoid_DC\|Transverse / Region, Cell class and subclass	DNHD1 SYNPO2 BMP2K PLEKHG3 RRAD	3.78e-05	197	85	5	a58af0ea82f76f2a7abac1f62629ff20d552fc63
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BMP2K VWA5A GATA2 GAS7 TESPA1	3.87e-05	198	85	5	cc5ca64749e2f4f1d373d9472824df85741702b7
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BMP2K VWA5A GATA2 GAS7 TESPA1	3.87e-05	198	85	5	d4d66f19df078bfc3a83d4664aaf9c7789bde1a5
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	PPIG DYNC2I1 BOD1L1 UTRN KPNA2	3.87e-05	198	85	5	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CCNE1 CCDC167 DEK SH2B2 KPNA2	3.87e-05	198	85	5	8bd9be3f57e7a27935c63c913e486872d52600e7
ToppCell	COVID-19_Convalescent-Non-classical_Monocyte\|COVID-19_Convalescent / Disease condition and Cell class	CCNE1 EVL CEBPB UTRN SH2B2	3.96e-05	199	85	5	c9250c80dd5bc3d27c6065b99119ff7dcf392e84
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	PPIG BOD1L1 DEK UTRN INO80D	3.96e-05	199	85	5	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	COVID-19_Convalescent-Non-classical_Monocyte-\|COVID-19_Convalescent / Disease condition and Cell class	CCNE1 EVL CEBPB UTRN SH2B2	3.96e-05	199	85	5	996a207b8b91e10dd018dc07aaf5ecd473bfeaad
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Myeloid\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CCNE1 NACA2 GATA2 MAST1	7.47e-05	117	85	4	f0c738b6b850733f9af68704172554177a1c1198
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Myeloid-Megakaryocyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CCNE1 NACA2 GATA2 MAST1	7.47e-05	117	85	4	b5cb9d69ddd42331134f7e4bd51bd1c31030893c
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2\|Thalamus / BrainAtlas - Mouse McCarroll V32	GATA2 MECOM RP1 CNGB1	1.23e-04	133	85	4	29b0c2c682c6b97823e7d8d8ba1f5114044b30ba
ToppCell	COVID-19_Mild-Neu_2\|World / 5 Neutrophil clusters in COVID-19 patients	GPRASP1 MYO3A FHOD3 EYA3	1.50e-04	140	85	4	b1429028c52f84127b894b93b55961badcd5246f
ToppCell	Children_(3_yrs)-Immune-mast_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	BMP2K VWA5A GATA2 TESPA1	1.76e-04	146	85	4	f7349d63bb47f1f22ced8ff514edc1c11bc782e7
ToppCell	E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_A\|E18.5-samps / Age Group, Lineage, Cell class and subclass	SYNPO2 GAS7 FHOD3 KIAA0753	1.85e-04	148	85	4	5729826e8d45bf995e2efa6707c49e264d12d112
ToppCell	COVID-19-Epithelial_cells-Airway_mucous\|COVID-19 / group, cell type (main and fine annotations)	MECOM CCDC187 RP1 FOXI3	2.00e-04	151	85	4	8216462e723fec2797387929dde095370947e10a
ToppCell	368C-Myeloid-Mast_cell\|368C / Donor, Lineage, Cell class and subclass (all cells)	BMP2K VWA5A GATA2 TESPA1	2.05e-04	152	85	4	faf30245a1690aaa27c7be0832797c340e4af4d7
ToppCell	368C-Myeloid-Mast_cell-\|368C / Donor, Lineage, Cell class and subclass (all cells)	BMP2K VWA5A GATA2 TESPA1	2.05e-04	152	85	4	519c9ed05fdaf420e42147ffae1dc05a7f86fdd4
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GPRASP1 EVL PRDM16 TESPA1	2.15e-04	154	85	4	ec920cae12ea1d14b6c973f6e903f895f80e3c50
Drug	NcAg	IFNG PPIG EGF	8.94e-07	6	82	3	CID002795122
Drug	Acyclovir [59277-89-3]; Up 200; 17.8uM; PC3; HG-U133A	KPNA4 DENND2A PPIG SRC CLTA GAS7 XPC	6.71e-06	195	82	7	1960_UP
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	MAGI2 PRR36 BMP2K VWA5A GATA2 ASAP3 GAS7	6.93e-06	196	82	7	5604_DN
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A	CAPN9 MAGI2 CHRNA9 PLEKHG3 GAS7 INO80D FOXI1	7.41e-06	198	82	7	6053_DN
Drug	0317956-0000 [391210-11-0]; Down 200; 10uM; MCF7; HT_HG-U133A	PRR36 PLEKHG3 GAS7 SSR3 ARMCX2 FOXI1	6.65e-05	191	82	6	3855_DN
Drug	Syrosingopine [84-36-6]; Up 200; 6uM; MCF7; HT_HG-U133A	CEBPB BMP2K KIAA0586 ASAP3 PDAP1 ATP8B2	6.84e-05	192	82	6	6213_UP
Drug	Promethazine hydrochloride [58-33-3]; Down 200; 12.4uM; HL60; HT_HG-U133A	GPRASP1 VWA5A SRC INO80D ATP8B2 TIGD6	7.04e-05	193	82	6	3100_DN
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A	CCNE1 BMP2K SRC DNAJB4 ATP8B2 MED12	7.24e-05	194	82	6	7481_DN
Drug	(R)-(+)-Atenolol [56715-13-0]; Up 200; 15uM; MCF7; HT_HG-U133A	GPRASP1 PDAP1 EYA3 PRDM16 UTRN ATP8B2	7.45e-05	195	82	6	2855_UP
Drug	Budesonide [51333-22-3]; Up 200; 9.2uM; PC3; HT_HG-U133A	DENND2A CEBPB CHRNA9 WDR33 PLEKHG3 GATA2	7.45e-05	195	82	6	6330_UP
Drug	Naloxone hydrochloride [357-08-4]; Down 200; 11uM; PC3; HT_HG-U133A	DENND2A SRC ASAP3 TRRAP UTRN KIAA0753	7.67e-05	196	82	6	4645_DN
Drug	Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; MCF7; HT_HG-U133A	RFTN1 BMP2K VWA5A PLEKHG3 GATA2 MED12	7.67e-05	196	82	6	4965_DN
Drug	Condelphine [7633-69-4]; Down 200; 8.8uM; PC3; HT_HG-U133A	DENND2A EGF ASAP3 PDAP1 UTRN TIGD6	7.67e-05	196	82	6	6357_DN
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	CAPN9 PLEKHG3 GAS7 EYA3 TESPA1 TIGD6	7.67e-05	196	82	6	987_UP
Drug	Dehydroisoandosterone 3-acetate [853-23-6]; Down 200; 12.2uM; PC3; HT_HG-U133A	BMP2K VWA5A ASAP3 GAS7 SSR3 ARMCX2	7.67e-05	196	82	6	6673_DN
Drug	Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; PC3; HT_HG-U133A	WDR33 VWA5A ASAP3 ARMCX2 TESPA1 TIGD6	7.89e-05	197	82	6	3728_DN
Drug	Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A	RFTN1 PRR36 WDR33 GATA2 PDAP1 ARMCX2	7.89e-05	197	82	6	3335_DN
Drug	Dimenhydrinate [523-87-5]; Down 200; 8.6uM; PC3; HT_HG-U133A	DENND2A EGF SRC GATA2 TRRAP UTRN	8.11e-05	198	82	6	6352_DN
Drug	Cefaclor [70356-03-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A	VWA5A PLEKHG3 ARMCX2 UTRN INO80D MED12	8.11e-05	198	82	6	4967_DN
Drug	Tocainide hydrochloride; Down 200; 17.4uM; MCF7; HT_HG-U133A	BMP2K VWA5A PDAP1 INO80D ATP8B2 TIGD6	8.11e-05	198	82	6	4838_DN
Drug	Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; HL60; HT_HG-U133A	BMP2K PLEKHG3 PDAP1 DNAJB4 ATP8B2 KIAA0753	8.34e-05	199	82	6	2404_DN
Drug	Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; MCF7; HT_HG-U133A	RFTN1 BMP2K GATA2 DNAJB4 GAS7 INO80D	8.34e-05	199	82	6	1509_DN
Drug	Mafenide hydrochloride [138-37-4]; Down 200; 18uM; MCF7; HT_HG-U133A	WDR33 VWA5A SRC GAS7 PRDM16 TIGD6	8.34e-05	199	82	6	2287_DN
Drug	Diflunisal [22494-42-4]; Down 200; 16uM; MCF7; HT_HG-U133A	RFTN1 PRR36 MYO9A PLEKHG3 MECOM XPC	8.57e-05	200	82	6	1490_DN
Drug	Pindolol [13523-86-9]; Down 200; 16.2uM; PC3; HT_HG-U133A	GPRASP1 EGF WDR33 PDAP1 DNAJB4 UTRN	8.57e-05	200	82	6	2075_DN
Disease	Mammary Carcinoma, Human	IFNG CCNE1 EVL EGF SRC MECOM RRAD DEK MED12 HNRNPR	1.58e-06	525	80	10	C4704874
Disease	Mammary Neoplasms, Human	IFNG CCNE1 EVL EGF SRC MECOM RRAD DEK MED12 HNRNPR	1.58e-06	525	80	10	C1257931
Disease	Mammary Neoplasms	IFNG CCNE1 EVL EGF SRC MECOM RRAD DEK MED12 HNRNPR	1.63e-06	527	80	10	C1458155
Disease	Breast Carcinoma	IFNG CCNE1 EVL EGF SRC MECOM RRAD DEK MED12 HNRNPR	1.96e-06	538	80	10	C0678222
Disease	Myelodysplasia	GATA2 MECOM	7.26e-06	2	80	2	C0026985
Disease	Ovarian Serous Adenocarcinoma	MYO3A MAST1 TRRAP	3.27e-05	23	80	3	C1335177
Disease	age of onset of asthma	RASSF6 SCUBE3 RPS26 TSLP	6.45e-05	79	80	4	OBA_2001001
Disease	Malignant neoplasm of breast	IFNG CCNE1 EVL EGF SRC MECOM BOD1L1 RRAD DEK MED12 HNRNPR	1.49e-04	1074	80	11	C0006142
Disease	myeloid leukemia (is_implicated_in)	IFNG GATA2	5.55e-04	13	80	2	DOID:8692 (is_implicated_in)
Disease	Short Rib-Polydactyly Syndrome	KIAA0586 DYNC2I1	5.55e-04	13	80	2	C0036996
Disease	Saldino-Noonan Syndrome	KIAA0586 DYNC2I1	6.47e-04	14	80	2	C0036069
Disease	Majewski Syndrome	KIAA0586 DYNC2I1	6.47e-04	14	80	2	C0024507
Disease	lupus nephritis (is_marker_for)	IFNG EGF	9.61e-04	17	80	2	DOID:0080162 (is_marker_for)
Disease	Disease Exacerbation	CCNE1 EGF XPC RPS26	1.07e-03	165	80	4	C0235874
Disease	respiratory syncytial virus infectious disease (is_marker_for)	IFNG TSLP	1.08e-03	18	80	2	DOID:1273 (is_marker_for)
Disease	Neoplasm Invasiveness	EGF SRC XPC DEK	1.60e-03	184	80	4	C0027626
Disease	glomerular filtration rate, renal transplant outcome measurement, donor genotype effect measurement	SYNPO2 CHRNA9	1.62e-03	22	80	2	EFO_0005199, EFO_0005208, EFO_0007892
Disease	Colitis	IFNG SRC	2.09e-03	25	80	2	C0009319
Disease	Antiglaucoma preparations and miotics use measurement	MECOM GAS7	2.26e-03	26	80	2	EFO_0009944
Disease	optic disc size measurement	DENND2A RFTN1 PLEKHG3 PRDM16	2.37e-03	205	80	4	EFO_0004832
Disease	chronic obstructive pulmonary disease	AEBP2 CC2D2A MECOM RPS26 VARS2 SSR3 TSLP	2.65e-03	688	80	7	EFO_0000341

Protein segments in the cluster

Peptide	Gene	Start	Entry
SPSKAGMNKRRKLKN	AEBP2	371	Q6ZN18
LMKGQLRDGRQDSKK	ASAP3	131	Q8TDY4
ASTLMLRRKGQEAKN	CCDC187	186	A0A096LP49
MSSKKNRKRLNQSAE	SPATA5	1	Q8NB90
DKARAKKAMLSEQNR	CCNE1	371	P24864
RNKDLSRKKDMNKRL	CHRNA9	386	Q9UGM1
GKGLMRNQKRESKTD	DNHD1	3586	Q96M86
RQRRTKQDMSKSNGK	BMP2K	981	Q9NSY1
RDQTKKRMAKPKNRA	ARMCX2	31	Q7L311
DTKLMQNSGRTKFKR	ATP8B2	271	P98198
MDRKERQKNRASING	RASSF6	201	Q6ZTQ3
NRQMRKSKGKLSARD	RFTN1	456	Q14699
DQSRKNMTSKNRGKR	EYA3	276	Q99504
NMTSKNRGKRKADAT	EYA3	281	Q99504
MRSKGRARKLATNNE	MECOM	1	Q03112
VARNSRKMAFRAKSK	RRAD	286	P55042
DVKNALKKMTRGRQS	OR8D2	296	Q9GZM6
EKMFDNGNFRRKRKR	FOXI3	226	A8MTJ6
AEGKRKRNKSVSNME	MAGI2	211	Q86UL8
RKAKDDATLSGKRMQ	PDAP1	161	Q13442
NFRGNKLRDKRLEKM	LRRC47	231	Q8N1G4
KLRRSSMRAASLKDK	KIAA1109	3591	Q2LD37
RQKSRTQALKQKMRS	DYNC2I1	476	Q8WVS4
LRTKSKASQRKAMNT	OR2W1	226	Q9Y3N9
MNKLLAKRRKAASQS	EVL	271	Q9UI08
SAAQARRRLMSGKVK	HNRNPR	301	O43390
SRKERDRQKQKSMSL	MED12	1461	Q93074
SNQRMGRSLLKSKDL	ITPRID2	706	P28290
RRSLEKEKNSLMNKA	CCDC167	46	Q9P0B6
AKMARRNKRPSAKEG	MAST1	1071	Q9Y2H9
RNKEVKGAFNRAMKR	OR12D1	286	P0DN82
KHNRNEEKRMRSRSK	PPIG	476	Q13427
AKKDDQMLKRRNVSS	KPNA2	41	P52292
RGNSSLMEKKLSRRL	BOD1L1	1056	Q8NFC6
EGIQTRNRKMSNKSK	GATA2	391	P23769
TKRMKISRKRLNADG	DNAJB4	176	Q9UDY4
RQQKVGTRKASLKMD	FHAD1	1371	B1AJZ9
DADMGRQNKNSKVRR	CC2D2A	21	Q9P2K1
RAGMSNRQKNKAKRM	BTAF1	201	O14981
GKKRVKRLSQSMESN	DENND2A	496	Q9ULE3
NKRTGKDRVRLQGSM	EGF	711	P01133
KERNSSGMARKAKRT	DEK	206	P35659
NNIAVRKSRDKAKMR	CEBPB	281	P17676
RKSRDKAKMRNLETQ	CEBPB	286	P17676
KRANHRERNKTRGKM	FHOD3	1266	Q2V2M9
SKTTQRNKQIAMGRK	CYTH3	61	O43739
MQLGRSGRRSQKQKH	FRMD6-AS1	1	P0C7T7
AKKMDNFLRGDNSRK	INO80D	511	Q53TQ3
AAKTGKRKRSQMLFR	IFNG	146	P01579
MFDNGNFRRKRKRKS	FOXI1	206	Q12951
RQRRTKQDMSKSNGK	BMP2KL	231	Q5H9B9
MQKDRRKLKRFGANV	CAPN9	401	O14815
KGSLKMLRKSINQDR	SCUBE3	581	Q8IX30
NTFDLMGKRRKQKRI	RP1	1996	P56715
RNRDMKAALRKLFNK	OR1A1	291	Q9P1Q5
NGRLRNLISDSMKAK	POLR1E	321	Q9GZS1
KFRSKMRAGKEANNR	GPRASP1	316	Q5JY77
VRDRQGRKMSKSLGN	VARS2	651	Q5ST30
RASQLARKMKKEAAS	UTRN	1541	P46939
MGSNKSKPKDASQRR	SRC	1	P12931
MANKGNKKRRQFSLE	TIGD6	1	Q17RP2
AMNEIRAKKRLRQSG	SPAG7	206	O75391
RQLNEKARAAGMKGK	PLEKHG3	456	A1L390
KARRKSTQAGDDLMR	GAS7	371	O60861
MDNKRDKAKAGAAAR	PRR36	1	Q9H6K5
MRSKARARKLAKSDG	PRDM16	1	Q9HAZ2
SRLKMNRQPVKDRKA	KIAA0753	541	Q2KHM9
NMNLKDLSKIRGRKR	SP140L	251	Q9H930
TRKLSEADNRKMSRK	SSR3	101	Q9UNL2
NPKSSKQAKDVSRMR	CLTA	221	P09496
RRMLRSNNKPKEEKS	CNGB1	1081	Q14028
GRDENTMKNIFSKKR	SETDB2	416	Q96T68
EKGSARMKKRSRNTL	TICRR	1081	Q7Z2Z1
RGAQLFAKRQSRMEK	SYNPO2	871	Q9UMS6
RGATRQKKTMKLSRA	PLCH2	611	O75038
TQINATQAMKKRRKR	TSLP	116	Q969D9
GKDRMQSKALRTLKR	VWA5A	446	O00534
ATKARVRKGFSLRNM	SH2B2	126	O14492
TNIRLKKMASRARKA	TRIM49D1	66	C9J1S8
MTKKRRNNGRAKKGR	RPS26	1	P62854
SRARKSLFQKNLMGR	TESPA1	436	A2RU30
LTFDGKRMRKAVNRK	WDR33	41	Q9C0J8
MVKGFSNRARKARLA	XPC	706	Q01831
NKNRNSKLRRLMTFA	TRRAP	1851	Q9Y4A5
RTKKGQNMTKDIRTN	KIAA0586	556	Q9BVV6
RLKNFKNKGRDLETM	KPNA4	11	O00629
KAKQSRSEKRARKAM	NACA2	66	Q9H009
KRRQQLRKDKMSSFK	MYO3A	1361	Q8NEV4
NKAKTRLSLIRRSMG	MYO9A	2266	B2RTY4